National Medical Care Company (TADAWUL: 4005)
Saudi Arabia
· Delayed Price · Currency is SAR 162.20
-0.80 (-0.49%)
Nov 20, 2024, 3:17 PM AST
National Medical Care Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,221 | 1,082 | 917.93 | 845.38 | 808.95 | 708.39 | Upgrade
|
| Revenue Growth (YoY) | 18.13% | 17.85% | 8.58% | 4.50% | 14.20% | -7.25% | Upgrade
|
| Cost of Revenue | 787.27 | 714.93 | 630.99 | 601.08 | 587.78 | 546.72 | Upgrade
|
| Gross Profit | 433.72 | 366.85 | 286.95 | 244.3 | 221.17 | 161.67 | Upgrade
|
| Selling, General & Admin | 151.84 | 124.53 | 93.08 | 79.09 | 107.06 | 73.3 | Upgrade
|
| Other Operating Expenses | -5.18 | -4.03 | -8.35 | -8.19 | - | - | Upgrade
|
| Operating Expenses | 168.54 | 120.13 | 89.68 | 79.9 | 107.06 | 73.3 | Upgrade
|
| Operating Income | 265.17 | 246.72 | 197.27 | 164.4 | 114.11 | 88.37 | Upgrade
|
| Interest Expense | -17.51 | -3.5 | - | - | - | -2.22 | Upgrade
|
| Interest & Investment Income | 23.18 | 21.37 | 1.24 | - | 0.21 | 6.75 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 8.97 | 9.81 | Upgrade
|
| EBT Excluding Unusual Items | 270.84 | 264.59 | 198.5 | 164.4 | 123.3 | 102.71 | Upgrade
|
| Pretax Income | 270.84 | 264.59 | 198.5 | 164.4 | 123.3 | 102.71 | Upgrade
|
| Income Tax Expense | -3.61 | 23.67 | 28.43 | 28.04 | 26.03 | 22.62 | Upgrade
|
| Net Income | 274.45 | 240.93 | 170.07 | 136.36 | 97.27 | 80.09 | Upgrade
|
| Net Income to Common | 274.45 | 240.93 | 170.07 | 136.36 | 97.27 | 80.09 | Upgrade
|
| Net Income Growth | 17.85% | 41.66% | 24.73% | 40.19% | 21.45% | 28.80% | Upgrade
|
| Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 | 45 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 | 45 | Upgrade
|
| Shares Change (YoY) | -0.10% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 6.13 | 5.37 | 3.79 | 3.04 | 2.17 | 1.79 | Upgrade
|
| EPS (Diluted) | 6.13 | 5.37 | 3.79 | 3.04 | 2.17 | 1.79 | Upgrade
|
| EPS Growth | 17.96% | 41.66% | 24.73% | 40.19% | 21.45% | 28.80% | Upgrade
|
| Free Cash Flow | -321.13 | 412.73 | 185.83 | 61.61 | 93.18 | 152.04 | Upgrade
|
| Free Cash Flow Per Share | -7.17 | 9.20 | 4.14 | 1.37 | 2.08 | 3.39 | Upgrade
|
| Dividend Per Share | 2.000 | 2.000 | 1.000 | 1.000 | 1.000 | 2.000 | Upgrade
|
| Dividend Growth | 100.00% | 100.00% | 0% | 0% | -50.00% | 100.00% | Upgrade
|
| Gross Margin | 35.52% | 33.91% | 31.26% | 28.90% | 27.34% | 22.82% | Upgrade
|
| Operating Margin | 21.72% | 22.81% | 21.49% | 19.45% | 14.11% | 12.47% | Upgrade
|
| Profit Margin | 22.48% | 22.27% | 18.53% | 16.13% | 12.02% | 11.31% | Upgrade
|
| Free Cash Flow Margin | -26.30% | 38.15% | 20.24% | 7.29% | 11.52% | 21.46% | Upgrade
|
| EBITDA | 316.2 | 290.94 | 239.17 | 214.56 | 170.31 | 157.04 | Upgrade
|
| EBITDA Margin | 25.90% | 26.89% | 26.05% | 25.38% | 21.05% | 22.17% | Upgrade
|
| D&A For EBITDA | 51.03 | 44.22 | 41.9 | 50.16 | 56.2 | 68.67 | Upgrade
|
| EBIT | 265.17 | 246.72 | 197.27 | 164.4 | 114.11 | 88.37 | Upgrade
|
| EBIT Margin | 21.72% | 22.81% | 21.49% | 19.45% | 14.11% | 12.47% | Upgrade
|
| Effective Tax Rate | - | 8.94% | 14.32% | 17.06% | 21.11% | 22.02% | Upgrade
|
| Advertising Expenses | - | - | - | - | 0.99 | 0.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.